Skip to Main Content

Author Details

Steven Z Pavletic
Center for Cancer Research, National Cancer Institute, National Institutes of Health
1987
335
66
PMIDPaper TitleJournal TitlePublished Year
37584292Red cell distribution width as a new prognostic biomarker in refractory chronic graft-<i>versus</i>-host disease.Haematologica2024
37584292Red cell distribution width as a new prognostic biomarker in refractory chronic graft-<i>versus</i>-host disease.Haematologica2024
36322878Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD.Blood Adv2023
36229646Chronic gvhd dictionary-eurograft cost action initiative consensus report.Bone Marrow Transplant2023
35615928Durable discontinuation of systemic therapy for chronic graft-<i>versus</i>-host disease: myth or reality?Haematologica2023
36322878Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD.Blood Adv2023
38026221Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA.iScience2023
37707875W"H-Y" antigen/HLA complexes in chronic GVHD.Blood2023
37684526Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease.Bone Marrow Transplant2023
37474729Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease.Bone Marrow Transplant2023
37267435Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes.Blood Adv2023
37131307Forty years of hematopoietic stem cell transplantation in Croatia: First-World options and First-World science.Croat Med J2023
37256121Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective.Front Immunol2023
37195774Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes: The Current Landscape and Future Directions.Cancer J2023
37129971Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.JCI Insight2023
38026221Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA.iScience2023
37707875W"H-Y" antigen/HLA complexes in chronic GVHD.Blood2023
37684526Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease.Bone Marrow Transplant2023
35615928Durable discontinuation of systemic therapy for chronic graft-<i>versus</i>-host disease: myth or reality?Haematologica2023
37256121Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective.Front Immunol2023
37474729Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease.Bone Marrow Transplant2023
37267435Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes.Blood Adv2023
37131307Forty years of hematopoietic stem cell transplantation in Croatia: First-World options and First-World science.Croat Med J2023
37129971Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.JCI Insight2023
37195774Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes: The Current Landscape and Future Directions.Cancer J2023
36229646Chronic gvhd dictionary-eurograft cost action initiative consensus report.Bone Marrow Transplant2023
34599519The clinical landscape of chronic graft-versus-host disease management in 2021.Br J Haematol2022
35527712Abnormal liver tests are not sufficient for diagnosis of hepatic graft-versus-host disease in critically ill patients.Hepatol Commun2022
35522969The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease.Blood Adv2022
36348353Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients.J Transl Med2022
35882499A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease.Blood Adv2022
36083121Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials.Blood Adv2022
35878742Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria.Transplant Cell Ther2022
35747850Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease.Hemasphere2022
35781099Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-versus-Host Disease Studies.Transplant Cell Ther2022
35662591Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.Transplant Cell Ther2022
34628648Meaningful response criteria for myelodysplastic syndromes.Br J Haematol2022
34599519The clinical landscape of chronic graft-versus-host disease management in 2021.Br J Haematol2022
35114411Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.Transplant Cell Ther2022
34875023Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.Rheumatology (Oxford)2022
35527712Abnormal liver tests are not sufficient for diagnosis of hepatic graft-versus-host disease in critically ill patients.Hepatol Commun2022
35662591Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.Transplant Cell Ther2022
35781099Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-versus-Host Disease Studies.Transplant Cell Ther2022
35522969The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease.Blood Adv2022
35747850Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease.Hemasphere2022
35882499A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease.Blood Adv2022
36348353Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients.J Transl Med2022
36083121Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials.Blood Adv2022
35878742Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria.Transplant Cell Ther2022
34875023Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.Rheumatology (Oxford)2022
  • 1 - 50 of 670

Recommended Authors

Lohith Gowda
Yale Cancer Center and Yale School of Medicine
Career Start Year 2018
Number of shared co-authors 2
Reem Elfeky
GOS Hospital for Children NHS Foundation Trust, University College London
Career Start Year 2014
Number of shared co-authors 1
Molly Maloy
Memorial Sloan Kettering Cancer Center
Career Start Year 2013
Number of shared co-authors 2
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 3
Rachel Cook
2University of Wisconsin School of Medicine and Public Health
Career Start Year 2008
Number of shared co-authors 2
Sung Won Choi
University of Michigan ann arbor
Career Start Year 2005
Number of shared co-authors 8
Laura F Newell
Oregon Health and Science University
Career Start Year 2003
Number of shared co-authors 5
Susan Geyer
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 2
Ivan Pasic
Princess Margaret Cancer Centre
Career Start Year 2001
Number of shared co-authors 0
Michiyo Sakiyama
the Lifestyle Related Disease Medical Center
Career Start Year 2000
Number of shared co-authors 0
Xingmin Feng
and Blood Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 2
Angela G Fleischman
University of California Irvine
Career Start Year 1998
Number of shared co-authors 3
Masahiro Kami
Medical Governance Research Institute
Career Start Year 1997
Number of shared co-authors 0
Leslie Lehmann
Dana Farber Cancer Institute/Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 2
Austen Worth
Great Ormond Street Hospital for Children NHS Foundation Trust
Career Start Year 1995
Number of shared co-authors 0
Adetola A Kassim
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 8
Gabrielle Meyers
Oregon Health and Science University
Career Start Year 1994
Number of shared co-authors 4
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 2
Roslyn B Mannon
University of Nebraska Medical Center
Career Start Year 1992
Number of shared co-authors 0
Paul L Martin
Duke University Medical Center
Career Start Year 1990
Number of shared co-authors 5
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 8
Volker Eckstein
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Joseph Schwartz
Icahn School of Medicine at Mount Sinai
Career Start Year 1990
Number of shared co-authors 1
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 2
Maura Rossetti
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 5
Dietger Niederwieser
University of Leipzig
Career Start Year 1982
Number of shared co-authors 7
Kenneth B Miller
Tufts Medical Center
Career Start Year 1981
Number of shared co-authors 4
Stefan Burdach
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 1
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 0

Collaborators

Edward W Cowen
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers 47
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 42
Daniel H Fowler
National Cancer Institute, National Institutes of Health
Co-authored papers 36
Frances T Hakim
National Cancer Institute
Co-authored papers 35
Ronald E Gress
National Cancer Institute, National Institutes of Health
Co-authored papers 34
Kristin Baird
National Cancer Institute, National Institutes of Health
Co-authored papers 30
Jacqueline W Mays
National Institute of Dental and Craniofacial Research, National Institutes of Health
Co-authored papers 25
Jeremy J Rose
National Cancer Institute
Co-authored papers 15
Sophie Paczesny
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 11
John F DiPersio
Washington University School of Medicine
Co-authored papers 9
Matin M Imanguli
Rutgers Robert Wood Johnson Medical School
Co-authored papers 9
Richard T Maziarz
Oregon Health & Science University
Co-authored papers 8
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 6
James D Bowen
Swedish Neuroscience Institute
Co-authored papers 6
Alan S Wayne
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Co-authored papers 6
David C Halverson
National Cancer Institute, National Institutes of Health
Co-authored papers 6
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Co-authored papers 5
Haley B Naik
University of California San Francisco
Co-authored papers 5
Effie W Petersdorf
Fred Hutchinson Cancer Center
Co-authored papers 5
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 4
Geoffrey D E Cuvelier
University of Manitoba
Co-authored papers 4
Jorge Cortes
Georgia Cancer Center
Co-authored papers 4
Stephan A Grupp
Co-authored papers 3
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 3
Susan Dhamala
National Institute of Dental and Craniofacial Research
Co-authored papers 3
Sabina De Geest
Institute of Nursing Science, University of Basel
Co-authored papers 3
David A Rizzieri
Duke University Medical Center
Co-authored papers 3
Sean Agbor-Enoh
Co-authored papers 3
John D Dickinson
University of Nebraska Medical Center (UNMC)
Co-authored papers 2
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Release 1.2